Tasly Pharmaceutical Group Co. Ltd. announced earnings results for the fourth quarter ended March 31, 2020. For the fourth quarter, the company announced sales was CNY 3,952.806 million compared to CNY 4,571.368 million a year ago. Operating income was CNY 366.776 million compared to CNY 548.973 million a year ago. Net income was CNY 294.865 million compared to CNY 448.188 million a year ago. Basic earnings per share from continuing operations was CNY 0.1955 compared to CNY 0.2971 a year ago.